These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10808770)

  • 1. Appetite suppressants and cardiac valvulopathy. Current clinical perspectives.
    Gross SB
    Adv Nurse Pract; 1999 Oct; 7(10):36-40. PubMed ID: 10808770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants].
    Goldstein SE; Levy Y; Shoenfeld Y
    Harefuah; 1998 Dec; 135(11):489-92, 568. PubMed ID: 10911459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of fenfluramine/dexfenfluramine-induced cardiac valvulopathy.
    Pallasch TJ
    J Calif Dent Assoc; 1999 May; 27(5):400-4. PubMed ID: 10528558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appetite-suppressing drugs and valvular heart disease.
    Cannistra LB; Gaasch WH
    Cardiol Rev; 1999; 7(6):356-61. PubMed ID: 11208248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anorexigen-related cardiopulmonary toxicity.
    Gross SB; Lepor NE
    Rev Cardiovasc Med; 2000; 1(2):80-9, 102. PubMed ID: 12457145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Valvular heart disease and primary pulmonary hypertension associated with fenfluramine-phentermine].
    Wolf I; Mouallem M; Farfel Z
    Harefuah; 1998 Dec; 135(11):515-7. PubMed ID: 10911468
    [No Abstract]   [Full Text] [Related]  

  • 7. Appetite suppressants and valvular heart disease.
    Seghatol FF; Rigolin VH
    Curr Opin Cardiol; 2002 Sep; 17(5):486-92. PubMed ID: 12357124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine.
    Gardin JM; Schumacher D; Constantine G; Davis KD; Leung C; Reid CL
    JAMA; 2000 Apr; 283(13):1703-9. PubMed ID: 10755496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet medications and valvular heart disease: the current evidence.
    Barasch A; Safford MM
    Spec Care Dentist; 2002; 22(3):108-14. PubMed ID: 12240890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience.
    Teramae CY; Connolly HM; Grogan M; Miller FA
    Mayo Clin Proc; 2000 May; 75(5):456-61. PubMed ID: 10807073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anorexigen-induced cardiac valvulopathy and female gender.
    Naqvi TZ; Gross SB
    Curr Womens Health Rep; 2003 Apr; 3(2):116-25. PubMed ID: 12628081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appetite-suppressant drugs and valvular heart disease.
    Shapiro S
    N Engl J Med; 1999 Feb; 340(6):477-8; author reply 478-80. PubMed ID: 9988622
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac valvulopathy.
    Alexander RE
    J Am Dent Assoc; 2000 Jul; 131(7):862, 864, 866 passim. PubMed ID: 10916324
    [No Abstract]   [Full Text] [Related]  

  • 14. Heart valve disorders and appetite-suppressant drugs.
    Jick H
    JAMA; 2000 Apr; 283(13):1738-40. PubMed ID: 10755501
    [No Abstract]   [Full Text] [Related]  

  • 15. Valve disease due to appetite suppressants (cont'd).
    Prescrire Int; 1999 Aug; 8(42):115. PubMed ID: 11503830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fen-phen manufacturers, not physicians, are liable.
    Allen S; Henderson J
    Tex Med; 2000 May; 96(5):62-4. PubMed ID: 10843016
    [No Abstract]   [Full Text] [Related]  

  • 17. Taking things to heart.
    Hess MA
    J Am Diet Assoc; 2004 Jul; 104(7):1073; author reply 1073-4. PubMed ID: 15215760
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies confirm link between fen-phen and heart-valve disease.
    Harv Heart Lett; 1998 Dec; 9(4):4-6. PubMed ID: 9925979
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pulmonary hypertension and heart valve diseases induced by fenfluramine? Hypothesis or certitude? Myth or reality?].
    Godeau P; Cherin P; Tellier P
    Rev Med Interne; 1998 Oct; 19(10):700-3. PubMed ID: 9827440
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine.
    Gardin JM; Weissman NJ; Leung C; Panza JA; Fernicola D; Davis KD; Constantine GD; Reid CL
    JAMA; 2001 Oct 24-31; 286(16):2011-4. PubMed ID: 11667938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.